You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RIGL Exercise Disclosure
Schorno Dean L · SEC Form 4 · Filed Sep 3, 2026
Exercise
Calculated transaction value
$0
Schorno Dean L EVP & Chief Financial Officer
RIGL
Transaction date
Sep 2, 2026
Public filing date
Sep 3, 2026
Filing lag
Filed 1 day later
RIGL daily price context
Close on/before transaction
$49.42
Sep 2, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (right to buy) on Common Stock
- Quantity / price
- 1,286 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0000905148-26-004080
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$144.01K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Rigel Pharmaceuticals Inc RIGL Current | Exercise | Sep 2, 2026 | $0 |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $8.81K |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $11.59K |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $48.4K |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $31.12K |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $0 |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $0 |
| Rigel Pharmaceuticals Inc RIGL | Exercise | Sep 2, 2026 | $0 |
| Rigel Pharmaceuticals Inc RIGL | Disposition | Sep 1, 2026 | $44.08K |